Bergløv A,Hallager S,Weis N. . .Hepatitis E during pregnancy: maternal and foetal case‐fatality rates and adverse outcomes-a systematic review. 2019 Nov, 26(11) : 1240-8.
Bigna JJ,Modiyinji AF,Nansseu JR,Amougou MA,Nola M,Kenmoe S,Temfack E,Njouom R . .Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis. BMC pregnancy and childbirth, 20(1) : 1-1.
Yasmeen T,Hashmi HA,Taj A . .Fetomaternal outcome with hepatitis e in pregnancy. 2013 Oct, 1(10) : 711-4.
Kumar A,Devi SG,Kar P,Agarwal S,Husain SA,Gupta RK,Sharma S. . .Association of cytokines in hepatitis E with pregnancy outcome. , : .
Cytokine . .. 2014 Jan, 1(1) : 95-104.
Shinde NR,Patil TB,Deshpande AS,Gulhane RV,Patil MB,Bansod YV. . .Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy. Annals of medical and health sciences research., : .
Bose PD,Das BC,Kumar A,Gondal R,Kumar D,Kar P . .High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. 2011 Jun, 1(6) : 1107-13.
Kar P,Sengupta A . .A guide to the management of hepatitis E infection during pregnancy. Expert Review of Gastroenterology & Hepatology. 2019 Mar, 4(3) : 205-11.
Aslan AT,Balaban HY . .Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. 2020 Oct, 7(37) : 5543.
Microbiology Newsletter Clinical . .. 2020 Nov, 1(21) : 171-9.
Obiri-Yeboah D,Asante Awuku Y,Adu J,Pappoe F,Obboh E,Nsiah P,Amoako-Sakyi D,Simpore J . .Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. 2018 Jan, 25(1) : e0191685.
Lhomme S,Marion O,Abravanel F,Izopet J,Kamar N. . .Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. 2020 Feb;9, (2) : 331.
Karna R,Hazam RK,Borkakoti J,Kumar A,Kar P. . .A 5-year singlecenter experience of hepatitis E virus infection during pregnancy. , : .
. .. 2020 Mar, 1(2) : 135-8.
Goel A,Aggarwal R. Hepatitis A . .E: epidemiology, clinical course, prevention, and treatment. 2020 Jun, 1(2) : 315-30.
Cheung CK,Wong SH,Law AW,Law MF . .Transfusion-transmitted hepatitis E: What we know so far?. 2022 Jan, 7(1) : 47.
Ahmad T,Hui J,Musa TH,Behzadifar M,Baig M. . .Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis. 2020 Mar;40, (2) : 136-46.
Zaman K,Dudman S,Stene-Johansen K,Qadri F,Yunus M,Sandbu S,Gurley ES,Overbo J,Julin CH,Dembinski JL,Nahar Q. . .HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. 2020 Jan, 1(1) : e033702.
Aggarwal R,Goel A . .Natural history, clinical manifestations, and pathogenesis of hepatitis E virus genotype 1 and 2 infections. 2019 Jul, 1(7) : a032136.
Khan SA,Khan Z,Alam Z,Sana H,Ali M,Zaman N,Ualiveya D,Rizwan M,Suleman M. Hepatitis . .E virus sero-prevalence among pregnant women in Khyber Pakhtunkhwa Pakistan. Clinical Immunology Communications. 2022 Apr, 4 : .
Farshadpour F,Taherkhani R,Ravanbod MR,Eghbali SS,Taherkhani S,Mahdavi E.,Prevalence E. . .risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. 2018 Jan, 12(1) : e0191090.